Product Details | |
Generic Name | Pazopanib |
Strength | 400mg |
Medicine Form | Tablet |
Manufactured By | Novartis Pharmaceuticals |
Quantity | 30 Tablet |
Packaging Type | Box |
Votrient (Pazopanib 400 mg Tablets) is a targeted therapy used in the treatment of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy. Pazopanib is a tyrosine kinase inhibitor that works by blocking certain proteins involved in cancer cell growth and angiogenesis, thereby slowing the spread of cancer. Votrient offers a potent option for managing advanced cancers, improving progression-free survival rates. Our super specialty pharmacy provides high-quality Votrient with personalized treatment plans and expert support to ensure optimal care for cancer patients. Trust us for comprehensive and effective cancer care tailored to your specific needs.